.png)
SummaryGlobal pricing-intelligence platforms are broad but shallow on Germany, and retail repricing tools are built for pharmacy shelves, not for manufacturers. For a pricing or market-access team that needs German and DACH depth, the useful question is which tool actually carries historical German prices, AMNOG reimbursement amounts and supplier-level alerts, ideally in English. This guide compares the options for the DACH pharmaceutical market. It is written for professionals, not patients.
A pharmaceutical price monitoring tool tracks the prices of competitor and reference products over time and alerts the user to changes. For the German market that means monitoring the manufacturer, wholesale and pharmacy-purchase price, plus reimbursement-relevant values such as Festbetraege (reference prices) and AMNOG reimbursement amounts. The value lies less in a single snapshot than in the trend and the alert: knowing that a competitor moved, and by how much, in time to react.
German pricing is shaped by regulation that global databases summarise but rarely carry in depth. After a benefit assessment under the AMNOG, a reimbursement amount is negotiated under section 130b SGB V; reference prices (Festbetraege) cap reimbursement for defined groups; and the Arzneimittelpreisverordnung (AMPreisV) governs mark-ups. German list prices are updated twice a month, on the 1st and the 15th, and several European countries use German prices as an external reference, which makes German depth relevant well beyond Germany. The benefit-assessment framework is documented by the G-BA, and the reimbursement amount in section 130b SGB V.
The table scores tool categories on the criteria that decide usefulness for a DACH pricing or market-access team, rather than on cross-country breadth alone.
| Tool | DACH depth | Historical price data | AMNOG / Festbetraege | Alert granularity | English access | Integration / API |
|---|---|---|---|---|---|---|
| Pharmonitor (pharmazie.com) | deep, DACH-focused | since 2008 | integrated | supplier and price-type level | yes | REST API |
| Global platform (e.g. IQVIA, GlobalData) | broad, many countries | yes, varies | summary level | market level | yes | yes |
| DE price-monitoring vendor (e.g. PREISmonitoring) | DE-focused | yes | partial | product level | limited | varies |
| Classic pharmacy-tariff system | DE only | limited | partial | list level | no | limited |
The choice is not global versus local in the abstract, it is breadth versus depth. If the job is cross-country reference pricing across dozens of markets, a global platform such as IQVIA or GlobalData is built for that scale. If the job is to understand the German or DACH market precisely, competitor moves at supplier level, AMNOG outcomes, Festbetraege and their history, a DACH specialist carries detail the global summaries do not. Many teams run both: a global tool for breadth and a DACH-deep tool such as Pharmonitor for the market where the decisions are actually made.
A price today is a data point; a price series is a decision tool. Historical German price data, in Pharmonitor since 2008, shows how a group moved through Festbetrag adjustments, AMNOG negotiations and moratorium periods, which is what a pricing model needs. Pairing the series with the AMNOG reimbursement amount and the reference price turns raw numbers into a defensible pricing position, without stitching three sources together by hand. For the underlying database landscape, see our comparison of German drug databases.
A monthly market average is too coarse to act on. Useful alerts fire at the level where a decision is made: the specific price type (manufacturer, wholesale or pharmacy-purchase price) and, ideally, filtered by supplier, so a pricing lead sees exactly which competitor moved and on which price. Pharmonitor alerts on purchase, retail and pharmacy-purchase price and is filterable by supplier, which is the granularity a market-access team needs to respond rather than merely observe.
The right fit follows the role. Manufacturers watching competitor moves in DACH need supplier-level alerts and historical depth. Market-access and pricing leads need AMNOG and Festbetrag data alongside the series. Consultancies working project by project need English access and flexible export, without an annual enterprise commitment. The German pricing detail that feeds all three is described in our pharma pricing and market access page.
For the DACH market, the best price monitoring tool is not necessarily the broadest one. It is the one that carries German depth: historical prices, AMNOG and Festbetraege, supplier-level alerts and English access. pharmazie.com provides that depth through Pharmonitor, within the consolidated pharmaceutical data platform by DACON Datenbank Consulting GmbH that bundles 25+ specialist databases into a single search, exclusively for healthcare professionals, with product data across 50+ countries updated daily. The clearest way to judge the fit for your pricing work is a short demo.
Further reading: German drug pricing database · German drug databases compared
